Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock at a price of $20.41 per share on October 15, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., reported a transaction on October 15, 2024.
• Boughton sold 2,339 shares of Class A Common Stock at $20.41 per share.
• The sale was executed under a Rule 10b5-1 trading plan adopted on September 10, 2023.
• Following the transaction, Boughton directly owns 172,274 shares of Hims & Hers Health, Inc.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was executed under a pre-planned 10b5-1 trading plan, indicating it was likely not based on any specific positive or negative information about the company.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned through 10b5-1 trading plans to avoid accusations of insider trading. The market typically analyzes these sales in aggregate to gauge insider sentiment.

Stakeholder Impact

• The sale of shares by a company officer could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates